Not a good buy right now for an impatient entry: price is extended in a strong uptrend and sitting just below key resistance (R1 41.56) with RSI near the high end of neutral.
Near-term pattern stats also lean slightly negative (higher odds of small declines over the next day/week), which reduces the reward/risk of chasing here.
Fundamentals and analyst stance are constructive, but without a fresh catalyst, options/flow confirmation, or Intellectia buy signals, the setup is better suited to waiting for a dip rather than buying immediately.
Momentum: MACD histogram is positive (0.167) and expanding, supporting continued upside momentum.
RSI (6): 68.425 (upper-neutral, close to overbought), suggesting limited immediate upside before a pullback/consolidation is likely.
Key levels: Pivot 39.52 (first meaningful support zone). Resistance at R1 41.56 then R2 42.82; current post-market ~40.84 is closer to resistance than support, making the entry less attractive.
Positive Catalysts
Strong latest quarter growth (2025/Q4): revenue +9.75% YoY; net income and EPS +51.72% YoY.
Analyst remains positive: Outperform rating with raised price target.
Technical trend remains bullish with positive MACD and bullish moving-average stack.
Neutral/Negative Catalysts
than support increases pullback risk.
Financial Performance
Latest quarter: 2025/Q4.
Revenue: 106.482M, up 9.75% YoY (steady top-line growth).
Net income: 24.807M, up 51.72% YoY (strong profitability improvement).
EPS: 0.88, up 51.72% YoY (strong earnings leverage).
Overall: growth trends are positive and supportive of the longer-term uptrend.
Growth
Profitability
Efficiency
Analyst Ratings and Price Target Trends
Latest action (2025-12-17): Keefe Bruyette (Christopher McGratty) reiterated Outperform and raised PT to $44 from $42.
Pros: constructive outlook reflected by Outperform and higher PT; company execution supported by strong YoY earnings growth.
Cons: only limited, single-source recent coverage provided here; near-term setup is more extended than early-entry.
Wall Street analysts forecast FSUN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FSUN is 45.5 USD with a low forecast of 44 USD and a high forecast of 47 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Analyst Rating
Wall Street analysts forecast FSUN stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for FSUN is 45.5 USD with a low forecast of 44 USD and a high forecast of 47 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 40.050
Low
44
Averages
45.5
High
47
Current: 40.050
Low
44
Averages
45.5
High
47
Keefe Bruyette
Christopher McGratty
Outperform
maintain
$42 -> $44
AI Analysis
2025-12-17
Reason
Keefe Bruyette
Christopher McGratty
Price Target
$42 -> $44
AI Analysis
2025-12-17
maintain
Outperform
Reason
Keefe Bruyette analyst Christopher McGratty raised the firm's price target on FirstSun Capital to $44 from $42 and keeps an Outperform rating on the shares. The firm updated its estimates following recent conference updates and management meetings.
Piper Sandler
Neutral -> Overweight
upgrade
$6
2025-11-03
Reason
Piper Sandler
Price Target
$6
2025-11-03
upgrade
Neutral -> Overweight
Reason
Piper Sandler last night upgraded First Foundation (FFWM) to Overweight from Neutral with a price target of $6.75, up from $6. The firm aligned First Foundation's rating with FirstSun Capital (FSUN) using the exchange ratio tied to its pending merger that is expected to close in early Q2 of 2026.
Unlock Full Analyst Thesis， Get the complete breakdown of rating reason for FSUN
